We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

6869:TSESysmex Corporation Analysis

Data as of 2026-06-13 - not real-time

NT$79.40

Latest Price

7/10Risk

Risk Level: Medium

Executive Summary

J&V Energy Technology (6869.TW) is trading at TWD 79.4, well below its 20‑day (82.44) and 50‑day (83.82) simple moving averages, indicating a bearish short‑term price bias. The stock’s RSI of 41.4 suggests neutral momentum, while the MACD histogram remains negative, reinforcing the downside pressure. However, the company just announced a 187 MW solar portfolio acquisition that should generate roughly 270 million kWh annually, adding a clear growth catalyst. Despite a forward P/E of 7.76—far under the industry average of 20.5—and an attractive 6.3% dividend yield, the firm reports negative profit margins, a -55% max drawdown, and a debt‑to‑equity ratio of 153%, raising concerns about cash‑flow sustainability. The high 30‑day volatility (≈42%) and a beta of 0.5 point to modest market sensitivity but substantial price swings. In summary, the stock is undervalued on a forward basis and buoyed by a strategic acquisition, yet its weak fundamentals and leverage impose considerable risk.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • Price below short‑term SMAs and bearish MACD
  • Upcoming Q3 close of the 187 MW acquisition
  • High dividend yield but negative operating cash flow

Medium Term

1–3 years
Positive
Model confidence: 8/10

Key Factors

  • Forward P/E of 7.76 vs industry 20.5 suggests valuation upside
  • Acquired solar assets add ~270 GWh annual generation
  • Renewable‑energy tailwinds in Taiwan and supportive policy outlook

Long Term

> 3 years
Neutral
Model confidence: 7/10

Key Factors

  • Elevated debt‑to‑equity (153%) and negative free cash flow
  • Structural growth from renewable portfolio expansion
  • Dividend sustainability concerns despite attractive yield

Key Metrics & Analysis

Financial Health

Revenue Growth67.10%
Profit Margin-5.67%
P/E Ratio7.8
ROE-6.47%
ROA1.21%
Debt/Equity153.00
P/B Ratio2.4
Op. Cash FlowNT$-501119008
Free Cash FlowNT$-111933128
Industry P/E20.5

Technical Analysis

TrendBearish
RSI41.4
SupportNT$77.00
ResistanceNT$91.30
MA 20NT$82.44
MA 50NT$83.82
MA 200NT$102.42
MACDBearish
VolumeIncreasing
Fear & Greed Index89.86

Valuation

Target PriceNT$159.00
Upside/Downside100.25%
GradeUndervalued
TypeBlend
Dividend Yield6.30%

Risk Assessment

Beta0.50
Volatility41.58%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskLow
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.